Anoxic cerebral potassium accumulation reduced by phenytoin: mechanism of cerebral protection?
Results from a previous study suggested that the cerebral protective effect of phenytoin (PNT) might be linked to its ability to reduce cerebrospinal fluid potassium (K+) accumulation during anoxia. In the present study two PNT doses (50 and 150 mg/kg) were examined to determine the ability of PNT to reduce cerebrospinal fluid K+ in cisterna magna samples after 10 and 20 minutes of circulatory arrest. Also examined were two other protective treatments (pentobarbital, 33 mg/kg, and hypothermia to 35 C) which, in the hypoxic (F1O2 = 0.05) mouse, provide cerebral protection equivalent to PNT, 50 mg/kg. Both PNT doses significantly reduced cerebrospinal fluid K+ accumulation and tended to do so in a dose-related manner, similar to the dose-related cerebral protective effect of PNT. PNT, 50 mg/kg reduced K+ accumulation more effectively than either pentobarbital or hypothermia, whose protective effects are likely explained by a different mechanism (i.e., reduced cerebral metabolic rate). These data support the hypothesis that PNT-induced cerebral protection may be linked to its effect on cerebral K+ accumulation.
D000818:Animals; D002946:Cisterna Magna; D004305:Dose-Response Relationship, Drug; D006323:Heart Arrest / Q000378:metabolism; D007036:Hypothermia, Induced; D002534:Hypoxia, Brain / Q000378:metabolism*; D010424:Pentobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000008:administration & dosage / Q000494:pharmacology*; D011188:Potassium / Q000134:cerebrospinal fluid*; D011817:Rabbits
D010672:Phenytoin; D010424:Pentobarbital; D011188:Potassium